Tag Archives: DGCI

Torrent Pharma inks diabetic drug marketing pact with Glenmark Pharma

AHMEDABAD | MUMBAI | RAJKOT –  In a press release submitted to the Indian Bourses by Glenmark Pharma it said that, Ahmedabad headquartered Torrent Pharmaceuticals and Glenmark Pharmaceuticals Ltd have inked agreement for co-marketing of diabetic treatment drug Remogliflozin Etabonate in India. The press release submitted to the Indian Exchanges on Thursday read that, Glenmark